Semaglutide 2.4 mg clinical outcomes in patients with obesity or overweight in a real‐world setting: A 6‐month retrospective study in the United States (SCOPE)

Año publicación: 2024

Subir documento: https://onlinelibrary.wiley.com/doi/10.1002/osp4.737

Nombre investigadores: Aleksandrina Ruseva, Wojciech Michalak, Zhenxiang Zhao, Anthony Fabricatore, Bríain Ó Hartaigh, Devika Umashanker